TuHURA Biosciences, Inc.
HURA
$2.42
$0.020.83%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 95.76% | 94.84% | 51.42% | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 63.38% | 70.92% | 42.30% | -- | -- |
| Operating Income | -63.38% | -70.92% | -42.30% | -- | -- |
| Income Before Tax | -38.60% | -59.44% | -60.20% | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -38.60% | -59.44% | -60.20% | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -38.60% | -59.44% | -60.20% | -- | -- |
| EBIT | -63.38% | -70.92% | -42.30% | -- | -- |
| EBITDA | -64.08% | -72.06% | -43.24% | -- | -- |
| EPS Basic | 58.34% | 52.74% | -22.15% | -- | -- |
| Normalized Basic EPS | 59.54% | 57.85% | -1.66% | -- | -- |
| EPS Diluted | 58.34% | 52.77% | -22.04% | -- | -- |
| Normalized Diluted EPS | 59.54% | 57.85% | -1.66% | -- | -- |
| Average Basic Shares Outstanding | 156.69% | 69.07% | 49.69% | -- | -- |
| Average Diluted Shares Outstanding | 156.69% | 69.07% | 49.69% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |